GLP1 and GLP1/GIP are forms of medical weight loss medication.
What is the difference between GLP1 semaglutide and GLP1/ GIP tirzepatide?
Trizepatide is a dual glucose-dependent insulinotropic polypeptide–GLP-1 receptor agonist. This means this medication works on two different receptors, GIP and GLP-1. The GIP receptors are activated to improve insulin sensitivity, insulin secretion, satiety (feeling full), and fat burn (lipolysis). Simultaneously, the GLP-1 receptors are stimulated to decrease glucagon secretion, slow gastric emptying, and decrease appetite. Concurrent action on both GIP and GLP-1 produces weight loss, lowered cholesterol, and reduced cardiovascular risk for patients.
Q & A with Dr. Wes our Weight Loss Physician and Jerry Rodrguez RN-FACHE, MSN.
We love our customers, so feel free to visit during normal business hours.
2711 North Loop 1604 West, San Antonio, Texas 78258, United States
Mon | By Appointment | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | 09:00 am – 02:00 pm | |
Sun | Closed |
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.